Everads Enters License Agreement with Kriya for Development of Ocular Gene Therapy Candidates Using Everads' Suprachoroidal Delivery Technology
/PRNewswire/ -- Everads Therapy, an ophthalmology-focused biotechnology company developing a novel platform that enables non-surgical office-based delivery of...
Source: prnewswire.com